Document ID: chunk:federal_register_of_legislation:F2018L01178:reg:9:p2
Version: federal_register_of_legislation:F2018L01178
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 7431–9190

the following:
(a)          the worsening of bronchiolitis obliterans organising pneumonia within six months of commencing drug therapy; and
(b)          clinical improvement within weeks of ceasing drug therapy;
(11)      having a solid organ transplant, stem cell transplant or bone marrow transplant before the clinical worsening of bronchiolitis obliterans organising pneumonia;
(12)      undergoing a course of therapeutic radiation for the treatment of malignant neoplasm of the breast or malignant neoplasm of the lung within the two years before the clinical worsening of bronchiolitis obliterans organising pneumonia;
(13)      having bronchial obstruction immediately adjacent to a focus of pulmonary organisation, at the time of the clinical worsening of bronchiolitis obliterans organising pneumonia;
Note: bronchial obstruction is defined in the Schedule 1 - Dictionary.
(14)      inhaling high concentrations of a substance with irritant properties, where:
(a)          the inhalation has resulted in signs and symptoms of acute damage to the lower respiratory tract within the 48 hours after the inhalation; and
(b)          the clinical worsening of bronchiolitis obliterans organising pneumonia occurs within the 30 days following the inhalation of the substance;
(15)      inhaling sulphur mustard (mustard gas) resulting in signs and symptoms of acute damage to the lower respiratory tract within the 30 days before the clinical worsening of bronchiolitis obliterans organising pneumonia;
(16)      having gastro-oesophageal reflux disease at the time of the clinical worsening of bronchiolitis obliterans organising pneumonia;
(17)      inability to obtain appropriate clinical management for bronchiolitis obliterans organising pneumonia.